The promise and perils of AI in oncology The Lancet Oncology ++... ++...

The promise and perils of AI in oncology The Lancet Oncology https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00252-4/fulltext?dgcid=raven_jbs_etoc_email Jun 2026 Volume 27Number 6p649-760, e271-e316 https://www.thelancet.com/journals/lanonc/issue/vol27no6/PIIS1470-2045(26)X2005-8 MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial Dr Jay S Detsky, MD PhDa Send email to jay.detsky@sunnybrook.ca ∙ Adrian Wai Chan, MDa ∙ Daniel Moore-Palhares, MDa ∙ Amir H Safavi, MDa ∙ James Perry, MDb ∙ Mary Jane Lim Fat, MDb ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00088-4/abstract?dgcid=raven_jbs_etoc_feature_lanonc Cancer workforce—a global crisis https://www.thelancet.com/commissions-do/cancer-workforce?dgcid=raven_jbs_etoc_feature_lanoncworkforce26 A sufficiently resourced, multidisciplinary, workforce is essential for delivering cancer care and doing clinically relevant research, as well as being a major barrier to reducing disparities in cancer outcomes between high-income and low-income settings. The Lancet Oncology’s Commission on Cancer workforce—a global crisis provides actionable guidance for strengthening the global cancer workforce with an emphasis on reducing global disparities. The Commission models the current and future global landscape of common cancers and workforce personnel types to better understand the extent of the changing global cancer burden and workforce needs. Focusing on examples from sub-Saharan Africa and Latin America, the authors also examine obstacles to workforce development and retention in low-income and middle-income countries and propose pragmatic actions to address the workforce crisis.